We have located links that may give you full text access.
Mechanism of 6-hydroxynicotinate 3-monooxygenase, a flavin-dependent decarboxylative hydroxylase involved in aerobic nicotinic acid degradation.
Biochemistry 2019 Februrary 28
6-Hydroxynicotinate 3-monooxygenase (NicC) is a Group A FAD-dependent monooxygenase that catalyzes the decarboxylative hydroxylation of 6-hydroxynicotinic acid (6-HNA) to 2,5-dihydroxypyridine (2,5-DHP) with concomitant oxidation of NADH in nicotinic acid degradation by aerobic bacteria. Two mechanisms for the decarboxylative hydroxylation half-reaction have been proposed [Hicks, K. et al. (2016) Biochemistry 55, 3432 - 3446]. Results with the Bordetella bronchiseptica RB50 NicC here show that a homocyclic analogue of 6-HNA, 4-hydroxybenzoic acid (4-HBA), is decarboxylated and hydroxylated by NicC with a 420-fold lower catalytic efficiency than is 6-HNA. The 13 ( V/ K), measured with wild-type NicC by isotope ratio mass spectrometry following the natural abundance of 13 C in the CO2 product, is inverse for both 6-HNA (0.9989 ± 0.0002) and 4-HBA (0.9942 ± 0.0004), and becomes negligible (0.9999 ± 0.0004) for 5-chloro-6-HNA, an analogue that is 10-fold more catalytically efficient than 6-HNA. Covalently bound 6-HNA complexes of NicC are not observed by mass spectrometry. Comparative steady-state kinetic and equilibrium binding analyses of active site NicC variants (C202A, H211A, H302A, H47E, Y215F, Y225F) identify Tyr215 and His47 as critical determinants of both 6-HNA binding (( Kd Y215F)/( Kd WT) > 240; ( Kd H47E)/( Kd WT)> 350) and in coupling rates of 2,5-DHP and NAD+ product formation ([2,5-DHP]/[NAD+ ] = 1.00 (WT), 0.005 (Y215F), and 0.07 (H47E)]. Results of these functional analyses accord with an electrophilic aromatic substitution reaction mechanism in which His47-Tyr215 serves as the general base to catalyze substrate hydroxylation and refine the structural model for substrate binding by NicC.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app